Antimicrobial resistance in intensive care units

Clinics in Chest Medicine

Volumn 20, Issue 2, 1999, Pages 303-316

  Fridkin, S K ^a   Gaynes, R P ^a  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEPHALOSPORIN; CIPROFLOXACIN; IMIPENEM; METICILLIN; OFLOXACIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; CANDIDA ALBICANS; CRITICAL ILLNESS; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HOSPITAL INFECTION; HUMAN; INFECTION CONTROL; INTENSIVE CARE UNIT; PATIENT CARE; PRIORITY JOURNAL; REVIEW;

EID: 0033019498     PISSN: 02725231     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-5231(05)70143-X     Document Type: Article

References (62)

1. D. Abi-Said E. Anaissie O. Uzon The epidemiology of hematogenous candidiasis caused by different Candida species Clin Infect Dis 24 1997 1122 1128
2. L. Archibald L. Phillips McGowan J.E. Jr Antimicrobial resistance in hospitals and outpatients in the United States: The increasing importance of the intensive care unit Clin Infect Dis 24 1997 211 215
3. C.H. Ballow J.J. Schentag Trends in antibiotic utilization and bacterial resistance: Report of the National Nosocomial Resistance Surveillance Group Diagn Microbiol Infect Dis 15 1992 37S 42S
4. D. Beezhold S. Slaughter M.K. Hayden Skin colonization with vancomycin-resistant enterococci in hospitalized patients with bacteremia Clin Infect Dis 24 1997 704 706
5. M.J. Bonten M.K. Hayden C. Nathan Epidemiology of colonization of patients and environment with vancomycin-resistant enterococci Lancet 348 1996 1615 1619
6. J.M. Boyce M.M. Jackson G. Pugliese Methicillin-resistant Staphylococcus aureus (MRSA): A briefing for acute care hospitals and nursing facilities Infect Control Hosp Epidemiol 15 1994 105 115
7. J.M. Boyce S.M. Opal J.W. Chow Outbreak of multidrug-resistant Enterococcus faecium with transferable vanB class vancomycin resistance J Clin Microbiol 32 1994 1148 1153
8. D.R. Burwen S.N. Banerjee R.P. Gaynes Ceftazidime resistance among selected nosocomial gram-negative bacilli in the United States J Infect Dis 170 1994 1622 1625
9. J.W. Chow V.L. Yu D.M. Shlaes Epidemiologic perspectives of Enterobacter for the infection control professional Am J Infect Control 22 1994 195 201
10. D. Cooke A.J. Salter I. Phillips Antimicrobial misuse, antibiotic policies and information resources J Antimicrob Chemother 6 1980 435 443
11. B.N. Doebbeling G.L. Stanley C.T. Sheetz Comparative efficacy of alternative hand-washing agents in reducing nosocomial infections in intensive care units N Engl J Med 327 1992 88 93
12. N.J. Ehrenkranz Bland soap handwash or hand antisepsis? The pressing need for clarity Infect Control Hosp Epidemiol 13 1992 299 301
13. M.E. Evans K.J. Kortas Vancomycin use in a university medical center: Comparison with Hospital Infection Control Practices Advisory Committee Guidelines Infect Control Hosp Epidemiol 17 1996 356 359
14. S.K. Fridkin W.R. Jarvis Epidemiology of nosocomial fungal infections Clin Microbiol Rev 9 1996 499 511
15. S.K. Fridkin S.M. Pear T.H. Williamson The role of understaffing in central venous catheter-associated bloodstream infections Infect Control Hosp Epidemiol 17 1996 150 158
16. Fridkin SK, Steward CD, Edwards JR, et al: Surveillance of antimicrobial use and antimicrobial resistance in U.S. hospitals: Project ICARE Phase 2. Clin Infect Dis 1999, in press
17. S.K. Fridkin S.F. Welbel R.A. Weinstein Magnitude and prevention of nosocomial infections in the intensive care unit Infect Dis Clin North Am 11 1996 479 496
18. T.R. Frieden S.S. Munsiff D.E. Low Emergence of vancomycin-resistant Enterococcus in New York City Lancet 342 1993 490 491
19. Garner J.S. Hospital Infection Control Practices Advisory Committee Guideline for isolation precautions in hospitals. Part I. Evolution of isolation practices Am J Infect Control 24 1996 24 31
20. D.N. Gerding T.A. Larson Resistance surveillance programs and the incidence of gram-negative bacillary resistance to amikacin from 1967–1985 Am J Med 80 6B 1986 22 28
21. H.S. Gold R.C.J. Moellering Antimicrobial-drug resistance N Engl J Med 335 1996 1445 1453
22. D.A. Goldmann R.A. Weinstein R.P. Wenzel Strategies to prevent and control the emergence and spread of antimicrobial-resistant microorganisms in hospitals JAMA 275 1996 234 240
23. M. Graham Frequency and duration of handwashing in an intensive care unit Am J Infect Control 18 1990 77 81
24. R.P. Haley D.A. Bregman The role of understaffing and overcrowding in recurrent outbreaks of staphylococcal infection in a neonatal special-care unit J Infect Dis 245 1982 875 885
25. Hospital Infection Control Practices Advisory Committee Recommendations for preventing the spread of vancomycin resistance Infect Control Hosp Epidemiol 16 1996 105 113
26. G.A. Jacoby P. Han Detection of extended-spectrum β-lactamases in clinical isolates of Klebsiella pneumoniae and Escherichia coli J Clin Microbiol 34 1996 908 911
27. W.R. Jarvis Preventing the emergence of multidrug-resistant microorganisms through antimicrobial use controls: The complexity of the problem Infect Control Hosp Epidemiol 17 1996 490 495
28. W.R. Jarvis J.R. Edwards D.H. Culver Nosocomial infection rates in adult and pediatric intensive care units in the United States Am J Med 91 suppl 3B 1991 185S 191S
29. E.M. Johnson D.W. Warnock J. Luker Emergence of azole drug resistance in Candida species from HIV-infected patients receiving prolonged fluconazole therapy for oral candidosis J Antimicrob Chemother 35 1995 103 114
30. S.V. Johnson L.L. Hoey K. Vance-Bryan Inappropriate vancomycin prescribing based on criteria from the Centers for Disease Control and Prevention Pharmacotherapy 15 1995 579 585
31. J.A. Karas D.G. Pillay D. Muckart Treatment failure due to extended spectrum β-lactamase J Antimicrob Chemother 37 1996 203
32. C. Klem J.F. Dasta Efforts of pharmacy to reduce antibiotic resistance New Horiz 4 1996 377 384
33. Larson E.L. APIC Guidelines Committee APIC guideline for handwashing and hand antisepsis in health care settings Am J Infect Control 23 1995 251 269
34. E.L. Larson A. McGeer Z.A. Quraishi Effect of an automated sink on handwashing practices and attitudes in high-risk units Infect Control Hosp Epidemiol 12 1991 422 428
35. J.R. Maenza J.C. Keruly R.D. Moore Risk factors for fluconazole-resistant candidiasis in human immunodeficiency virus-infected patients J Infect Dis 173 1996 219 225
36. J.A. Mayer P.M. Dubbert M. Miller Increasing handwashing in an intensive care unit Infect Control 7 1986 259 262
37. L.F. McCaig J.M. Hughes Trends in antimicrobial drug prescribing among office-based physicians in the United States JAMA 273 1995 214 219
38. McGowan J.E. Jr Antimicrobial resistance in hospital organisms and its relaion to antibiotic use Rev Infect Dis 5 1983 1048
39. McGowan J.E. Jr Do intensive hospital antibiotic control programs prevent the spread of antibiotic resistance? Infect Control Hosp Epidemiol 15 1994 478 483
40. D. Monnet J.W. Biddle J.R. Edwards Evidence of interhospital transmission of extended-spectrum β-lactam–resistant Klebisella pneumoniae in the United States, 1986–1993 Infect Control Hosp Epidemiol 18 1997 492 498
41. M.A. Montecalvo D.K. Shay P. Patel Bloodstream infections with vancomycin-resistant enterococci Arch Intern Med 156 1996 1458 1462
42. J.G.J. Morris D.K. Shay J.N. Hebden Enterococci resistant to multiple antimicrobial agents, including vancomycin. Establishment of endemicity in a university medical center Ann Intern Med 123 1995 250 259
43. R.J. Olsen P. Lynch M.B. Coyle Examination gloves as barriers to hand contamination in clinical practice JAMA 270 1993 350 353
44. M.A. Pfaller R.N. Jones S.A. Messer National surveillance of nosocomial blood stream infection due to Candida albicans : Frequency of occurrence and antifungal susceptibility in the SCOPE Program Diagn Microbiol Infect Dis 31 1998 327 332
45. L. Piroth H. Aube J. Doise Spread of extended-spectrum β-lactamase–producing Klebsiella pneumoniae : are β-lactamase inhibitors of therapeutic value? Clin Infect Dis 27 1998 76 80
46. J. Quale D. Landman G. Saurina Manipulation of a hospital formulary to control an outbreak of vancomycin-resistant enterococci Clin Infect Dis 23 1996 1020 1025
47. J.H. Rex M.A. Pfaller M.G. Rinaldi Antifungal susceptibility testing Clin Microbiol Rev 6 1993 367 381
48. L.B. Rice E.C. Eckstein J. DeVente Ceftazidime-resistant Klebsiella pneumoniae isolates recovered at the Cleveland Department of Veterans Affairs Medical Center Clin Infect Dis 23 1996 118 124
49. M. Richards J.R. Edwards D.H. Culver Nosocomial infections in coronary care units in the United States Am J Cardiol 82 1998 789 793
50. Richards M, Edwards JR, Culver DH, et al: Nosocomial infections in medical intensive care in the United States. Crit Care Med 1998b, in press
51. R.P. Rifenburg J.A. Paladino S.C. Hanson Benchmark analysis of strategies hospitals use to control antimicrobial expenditures Am J Health Syst Pharm 53 1996 2054 2062
52. C. Salemi L. Becker R. Morrissey A clinical decision process model for evaluating vancomycin use with modified HICPAC guidelines Clinical Performance and Quality Health Care 1 1998 12 16
53. D.A. Schiappa M.K. Hayden M.G. Matushek Ceftazidime-resistant Klebsiella pneumoniae and Escherichia coli bloodstream infection: A case-control and molecular epidemiologic investigation J Infect Dis 174 1996 529 536
54. H. Seppala T. Klaukka J. Vuopio-Varkila The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland N Engl J Med 337 1997 441 446
55. D.M. Shlaes B. Binczewski L.B. Rice Emerging antimicrobial resistance and the immunocompromised host Clin Infect Dis 17 suppl 2 1993 S527 S536
56. D.M. Shlaes D.N. Gerding J.F. John Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: Guidelines for the prevention of antimicrobial resistance in hospitals Infect Control Hosp Epidemiol 18 1997 275 291
57. M.V. Singer R. Haft T. Barlam Vancomycin control measures at a tertiary-care hospital: impact of interventions on volume and patterns of use Infect Control Hosp Epidemiol 19 1998 248 253
58. S. Slaughter M. Hayden C. Nathan Effect of universal gown and glove use vs. glove-only use on acquisition of vancomycin-resistant enterococcus in a medical ICU Ann Intern Med 125 1996 448 456
59. C.W. Stratton H. Ratner P.E. Johnston Focused microbiologic surveillance by specific hospital unit as a sensitive means of defining antimicrobial resistance problems Diagn Microbiol Infect Dis 15 2 suppl 1992 11S 18S
60. P. Toltzis J.L. Blumer Antibiotic-resistant gram-negative bacteria in the critical care setting Pediatr Clin North Am 42 1995 687 702
61. C. Watanakunakorn Prescribing pattern of vancomycin in a community teaching hospital with low prevalence of vancomycin-resistant enterococci Infect Control Hosp Epidemiol 18 1997 767 769
62. White A.C. Jr R.L. Atmar J. Wilson Effects of requiring prior authorization for selected antimicrobials: expenditures, susceptibilities, and clinical outcomes Clin Infect Dis 25 1997 230 239